MediFind
Condition

Adrenocortical Carcinoma

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 37
  • Start Date: June 4, 2019
Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 18
  • Start Date: February 26, 2018
A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 57
  • Start Date: December 28, 2017
A Phase II Study of Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: September 22, 2017
Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 10
  • Start Date: April 18, 2017
Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 3000
  • Start Date: April 6, 2017
Familial Investigations of Childhood Cancer Predisposition
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 818
  • Start Date: January 13, 2017
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors